27325-97-9

Usage

Uses

Used in Organic Synthesis:
N-Methylethenesulfonamide is used as a solvent and reagent in organic synthesis for its ability to facilitate various chemical reactions, enhancing the efficiency and selectivity of the processes involved.
Used in Catalysis:
It is utilized as a chelating agent in catalytic processes due to its capability to form stable complexes with metal ions, which can improve the efficiency of catalytic reactions and contribute to the development of more sustainable catalytic systems.
Used in Metal Extraction:
N-Methylethenesulfonamide is employed in metal extraction as a chelating agent, where its ability to form stable complexes with metal ions aids in the separation and purification of metals from their ores or other sources.
Used in Environmental Applications:
Given its biodegradability and low potential for bioaccumulation, N-Methylethenesulfonamide is used in environmentally friendly applications where reducing the environmental impact of chemical processes is a priority.

InChI:InChI=1/C3H7NO2S/c1-3-7(5,6)4-2/h3-4H,1H2,2H3

Upstream product

• 1622-32-8 2-Chloroethanesulfonyl chloride 
• 74-89-5 methylamine 
• 593-51-1 methylamine hydrochloride 
• 6608-47-5 vinylsulfonyl chloride 

Downstream Products

• 301542-49-4 (E)-2-(2-Amino-5-chloro-3-pyridinyl)-N-methyl-1-ethenesulphonamide 
• 1346254-68-9 C₉H₁₂ClNO₂S 
• 95339-74-5 N-methyl-2-phenylethane-1-sulfonamide 

Relevant academic research and scientific papers

HERBICIDAL COMPOUNDS

Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.

HETEROARYL COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF

The present invention provides herein is a heteroaryl compound or a stereoisomer, a geometric isomer, a tautomer, a racemate, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, as well as a pharmaceutical composition containing the compound disclosed herein. The present invention also provides herein is use of the compound or the pharmaceutical composition thereof disclosed herein in the manufacture of a medicine for treating autoimmune diseases or proliferative diseases.

The first examples of rhodium-catalyzed 1,4-conjugate addition reactions of arylboronic acids with ethenesulfonamides

An unprecedented rhodium-catalyzed 1,4-conjugate addition of arylboronic acids with ethenesulfonamides resulting in the corresponding 2-arylethanesulfonamides is described. The amino substituent, the applied arylboronic acid, the type of Rh-catalyst, and the experimental conditions all affected the reaction outcome.

PROCESS FOR PREPARATION OF NARATRIPTAN HYDROCHLORIDE

The present invention relates to an improved process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide hydrochloride of formula (I) having less than 0.15 % area by HPLC of 3-(1-methyl-4-piperidinyl)-1H-indole-5- ethanesulfonamide (1A) and intermediates thereof.

Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

The compounds of the present invention are represented by the following aryl- and heteroaryl-substituted tetrahydrobenzazepine and dihydrobenzazapine derivatives having formulae I(A-E) and formula (II): where the carbon atom designated * is in the R or S configuration, and the substituents X and R1-R9 are as defined herein.